image: Forest plot of pooled prevalence of co-infection in patients infected with SARS-CoV-2. view more
Credit: Musuuza et al, PLOS ONE, 2021 (CC BY 4.0)
Almost 1 in 4 COVID-19 patients have another bacterial, viral or fungal infection simultaneously or subsequently, with such patients experiencing worse disease outcomes.
###
Article Title: Prevalence and outcomes of co-infection and superinfection with SARS-CoV-2 and other pathogens: A systematic review and meta-analysis
Funding: NS received research support for this work from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under Award Number DP2AI144244. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funding agency did not play any role in the study's design, data collection, analysis, decision to publish or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
Article URL: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0251170
Journal
PLOS ONE